Search the Newsreel

Medical Developments International Posts $626,000 Net Profit for FY2026

Medical Developments International Reports FY26 Net Profit of $0.6 Million with 9% Revenue Growth

Ascentage Pharma Lifts Revenue, Deepens Losses as U.S. Push and BTK Degrader Trials Advance

Insider Selling: WESCO International (NYSE:WCC) EVP Sells $1,247,052.00 in Stock

WESCO International's EVP Akash Khurana sold 3,400 shares of company stock for over $1.2 million, reducing his direct ownership by 11.04%. Despite the insider selling, analysts maintain a "Buy" rating for WESCO International, which recently reported stronger-than-expected quarterly earnings and pays a quarterly dividend. …

Goldman Sachs Maintains Colliers International Group(CIGI.US) With Hold Rating, Raises Target Price to $121

Goldman Sachs has reiterated its Hold rating on Colliers International Group (CIGI.US), indicating a neutral outlook for the stock. The firm has also increased its target price for CIGI.US to $121, suggesting a higher valuation expectation for the company's shares.

Ascentage Pharma: Revenue up 29%, but net loss widened on higher R&D and selling costs; cash reserves declined

Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates

ASCENTAGE PHARMA GROUP INTERNATIONAL Revenue for the first half of 2026 increased 29%year-over-year to US$44.5 million (RMB302.2 million), primarily attributable to increased product sales. Expanded executive leadership with appointments of Dr. Faical Miyara as Chief Business Officer and Mr. James Ziegler as Chief Commercial …

Price to earnings forward of Abundance International Limited – SGX:541

Miami International Holdings CFO Lance Emmons Sells 35,000 Shares Under Rule 10b5-1 Plan

Lance Emmons, EVP and CFO of Miami International Holdings, Inc. (MIAX), sold 35,000 common stock shares on August 17, 2026, at a weighted average price of $42.83 per share. This transaction was executed under a pre-established Rule 10b5-1 trading plan adopted in December 2025. …

Smith+Nephew CFO joins Baxter

John Rogers, the CFO of Smith+Nephew, is stepping down to take on the role of EVP and CFO at Baxter, effective in October. This move follows Smith+Nephew's recent reduction in its annual growth forecast and comes as the company navigates its RISE strategy, which …

Moderna Shares Surge 159% After Personalized mRNA Cancer Vaccine Succeeds in Late-Stage Trial - Earnings Stability Report

Marriott International (NYSE: MAR) withholds 107 RSUs for exec tax payment

Marriott International (NYSE: MAR) reported that executive Neal Jones had 107 Class A common RSUs withheld on August 17, 2026, to cover taxes upon RSU vesting. The RSUs were valued at $355.49 per share for this tax-withholding disposition. Following this transaction, Neal Jones directly …

Moderna or Merck: Which Soaring Cancer Vaccine Stock Is the Better Buy?

Moderna and Merck announced a significant breakthrough with their personalized mRNA cancer vaccine, intismeran autogene, which in combination with Keytruda, met primary and secondary endpoints in a Phase 3 melanoma study. This news caused both stocks to surge, with Moderna more than doubling and …

Why Smoore International (SEHK:6969) Is Up 6.4% After Reporting Stronger 2026 Interim Earnings And Dividend Plan

Moderna (MRNA)’s Melanoma Vaccine Win: Big Opportunity, Bigger Expectations

Moderna, Inc. (NASDAQ:MRNA) has delivered a major boost to its turnaround story. Its personalized mRNA cancer vaccine, Intismeran, met the main goal of reducing melanoma recurrence and also showed a benefit in preventing the cancer from spreading when used with Merck's Keytruda. The result …

BioNTech Stock Surges 22% on Moderna Cancer Vaccine Win. Why the Gains Could Fade.

BioNTech, a former pioneer of mRNA cancer vaccines, was part of a broad rally Wednesday. Leerink analysts don’t expect the momentum to last. Continue Reading

Why Is Moderna (MRNA) Stock Rocketing Higher Today

What Happened? Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 144% in the afternoon session after its personalized mRNA cancer vaccine, developed with Merck, met key goals in a late-stage trial. The company noted in a press release that the treatment, Intismeran, reduced the risk …

Klarna Group plc 2026 Q2 - Results - Earnings Call Presentation (NYSE:KLAR) 2026-08-19

International Business Machines (NYSE:IBM) Stock Price Up 2% - Time to Buy?

Jiankun International Malaysia 2nd-Quarter 2026 Earnings Summary Table

Stock Market Today, Aug. 19: Moderna Skyrockets 177% on Positive Phase 3 Melanoma Data

Moderna's stock surged by 177% following the announcement of positive Phase 3 data for its melanoma treatment, intismeran autogene, when paired with Merck's KEYTRUDA. This significant increase in share price reflects investor optimism about the potential for intismeran in other cancer trials. The news …

Auckland Airport profit down slightly

ATN International holder sells 6,745 shares near $31.75 | ATNI Insider Trading

ATN International (ATNI) ten percent owner, Prior Cornelius B Jr, indirectly sold a total of 6,745 common shares through VI E-Cell Tropical Telecom Ltd. The sales occurred on August 17, 2026, for 5,745 shares at a weighted average price of $31.7931, and on August …

Insider Selling: ATN International (NASDAQ:ATNI) Major Shareholder Sells 5,745 Shares of Stock

ATN International (NASDAQ:ATNI) major shareholder Cornelius Prior Jr. sold 5,745 shares of the company's stock for $182,633.55, reducing his stake by 8.92% to 58,665 shares. The stock traded up 1.5% to $31.88, near its 12-month high, and has a market capitalization of $491 million …

WESCO International (NYSE: WCC) exec sells 3,400 shares near $368

Akash Khurana, EVP and Chief Information & Digital Officer at WESCO International (WCC), reported three open-market sales of common stock on August 17, 2026. He sold a total of 3,400 shares at weighted average prices ranging from $366.10 to $368.27. These transactions were not …

Wesco International EVP, Chief Info & Digital Off. Sold Shares Worth Over $1.2M

Khurana Akash, EVP, Chief Info & Digital Off. at Wesco International (WCC), sold common stock worth over $1.2 million on August 17, 2026. The sales were conducted at weighted average prices between $366.10 and $368.27. Following these transactions, Khurana Akash directly owns 27,403 shares …

WESCO EVP Akash Khurana sells $1.25m in company stock

Akash Khurana, EVP and Chief Information and Digital Officer at WESCO International Inc. (NYSE: WCC), sold company stock worth approximately $1.25 million on August 17, 2026. This transaction involved selling 3,400 shares at weighted average prices ranging from $366.1 to $368.27 per share. Following …

Honeywell International Inc. stock outperforms competitors despite losses on the day

Honeywell International Inc. (HON) saw its stock slip by 2.63% to $221.73, marking its fifth consecutive day of losses. Despite this, the stock's performance outpaced the broader market, which saw the S&P 500 Index (SPX) rise by 0.21% and the Dow Jones Industrial Average …

Honeywell (HON) Earnings Snapshot: EPS Misses Its Estimate under the Current Snapshot; Market Reaction: The Stock Loses 2.63% in the Latest Session - Pretax Income Report

Miami International (MIAX) director exercises options, sells 5,000 shares

Cynthia Schwarzkopf, a director at Miami International Holdings, Inc. (MIAX), recently executed an option exercise and sale sequence. She exercised 5,000 stock options at $12.00 per share and subsequently sold 5,000 common shares at a weighted average price of $42.85 per share. These transactions …

Brinker International FY 2026: Revenue $5.81B, EPS $10.87— 10-K Summary

Brinker International reported strong financial results for fiscal year 2026, with revenue reaching $5.81 billion and diluted EPS at $10.87. This improvement was primarily driven by robust comparable sales at Chili’s and growth in franchise royalty revenue. The company also focused on capital deployment, …

Comstock (LODE) Earnings Report: Profit Per Share Falls Below Its Benchmark; Trading Response: Shares Show Limited Movement in the Latest Reading - Profit Cycle Analysis

Philip Morris International Inc. stock underperforms Wednesday when compared to competitors despite daily gains

Philip Morris International Inc. (PM) shares increased by 1.23% on Wednesday, closing at $189.93. Despite this gain, the stock underperformed compared to the broader market, as the S&P 500 Index rose by 0.21% and the Dow Jones Industrial Average gained 0.22%. This marks the …

Should Innovex’s 5 Million Share Offering and Offshore Pivot Require Action From Innovex International (INVX) Investors?

Innovex International recently completed a 5 million share equity offering, which provides financial flexibility for its pivot towards higher-margin offshore and Subsea work, manufacturing consolidation, and acquisitions. While this move increases the share count, it supports the company's strategy to improve profitability and returns, …

Johnson Controls (NYSE: JCI) director to sell 3,300 shares

Johnson Controls International plc director Pierre E. Cohade plans to sell 3,300 shares of JCI common stock, valued at approximately $487,707.33, on the NYSE through Morgan Stanley Smith Barney LLC. The sale is scheduled for August 19, 2026, and the shares originate from restricted …

Moderna Nearly Triples On Its Cancer Vaccine's 'Landmark Win,' Merck Hits Record High

Moderna stock doubled Wednesday after its Merck-partnered cancer vaccine succeeded in a late-stage study of patients with melanoma. Continue Reading